This is a discussion on Rituxan fails (again) in late-stage lupus trial within the Biotechnology News forum, part of the Industry News and Updates category; Genentech and Biogen Idec were taking it on the chin this morning after researchers announced that Rituxan had failed in ...
|
|||||||
| Register | Help | Members List | Mark Forums Read |
|
|||
|
Genentech and Biogen Idec were taking it on the chin this morning after researchers announced that Rituxan had failed in a later-stage trial as a therapy for lupus. The failure won't harm the Read more...
More... |
![]() |
| Thread Tools | |
| Display Modes | |
|
|
|
||||
| Thread | Thread Starter | Forum | Replies | Last Post |
| Rituximab Phase 2/3 Trial Fails to Meet Primary End Point in Primary Progressive MS Medscape Medical News, April 16, 200 | industry_news | Other Clinical Pharmacy News | 0 | 04-17-2008 01:58 AM |
| Boehringer boasts of late-stage drug potential | industry_news | Biotechnology News | 0 | 04-08-2008 01:55 PM |
| Recentin Fails Lung Cancer Trial Reuters Health Information, February 27, 2008 | industry_news | Other Clinical Pharmacy News | 0 | 02-28-2008 12:13 AM |